February 8, 2017

Investigators' analyses of clinical data and information from a previous influenza outbreak revealed that oseltamivir 75 mg relative to no treatment was effective and affordable under all scenarios. However, oseltamivir 150 mg was not.

February 3, 2017

The Pharmaceutical Research and Manufacturers of America has announced leadership changes to some of its advocacy efforts as longtime SVP advocacy Jeff Bond is set to retire. 

February 1, 2017

The new dosage of Allergan and Ironwood Pharmaceutical’s drug should be available in the first quarter of this year.

February 1, 2017

Johnson & Johnson worldwide chairman, pharmaceuticals Joaquin Duato was elected chairman of the board, Novartis CEO Joseph Jimenez was elected chairman-elect and Amgen chairman and CEO Robert Bradway was named board treasurer.

January 31, 2017

Executives from several the pharmaceutical industry convened at the White House Tuesday for a meeting with President Donald Trump, Vice President Mike Pence and House Energy and Commerce Committee chairman Rep. Greg Walden, R-Ore. 

January 25, 2017
The FDA’s approval of the new formulation comes a little more than a year after it approved the nasal spray in a 4-mg formulation. 

 

January 23, 2017

FamilyWize’s Medicine Cabinet allows users to create a personal profile and easily find the lowest price for their prescriptions through FamilyWize’s website and mobile app. 

January 23, 2017

The campaign is aimed at highlighting those in the industry driving innovation and pointing to the opportunity that exists in tackling complex health conditions. 

January 20, 2017
The Food and Drug Administration approved the regimen of Opdivo and Yervoy as a treatment for metastatic melanoma in October 2015. 
January 20, 2017

The drug is indicated to treat adults with chronic idiopathic constipation.

January 19, 2017
The cream is indicated to treat persistent facial redness from rosacea in adults. 
January 19, 2017

Alongside the availability announcement, kaléo unveiled its Auvi-Q access program, AffordAbility, through which patients with commercial insurance will have an out-of-pocket cost of $0. 

January 18, 2017

The drug, indicated for pain severe enough to require daily, around-the-clock, long-term opioid treatment and patients for whom alternative therapy is inadequate, is formulated with Teva’s proprietary abuse-deterrent technology. 

January 18, 2017

The $960 million all-cash transaction is aimed at growing Lilly’s migraine pain management portfolio and will add a potential near-term launch to its late-stage pipeline. 

January 18, 2017

The study found that retrospective rebates, discounts and fees have increased from $67 billion in 2013 to $106 billion in 2015. 

January 17, 2017

Carsten Brun will oversee the company’s pharmaceutical arm in the United States, Canada, Central and Latin America, reporting to pharmaceutical division president and board of management member Dieter Weinand. 

 
January 12, 2017

The weekly Flu Index shows which populations are experiencing the most incidences of influenza each week based on Index methodology and does not measure actual levels or severity of flu activity, Walgreens noted.

January 11, 2017

Mayne Pharma acquired the products from GSK in August 2016, and they complement the company’s Doryx, the first branded product in its specialty brands division that it launched in 2015. 

January 10, 2017

The drug is indicated for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis or emphysema. 

January 10, 2017

Egalet said Arymo ER is the first drug approved using its proprietary Guardian Technology, which works to deter abuse and prevent the tablets from being manipulated for abuse or misuse. 

January 9, 2017

Johnson and Johnson worldwide chairman, pharmaceuticals, Joaquin  Duato will be the next board chairman of PhRMA. 

January 6, 2017

The number of drugs the FDA approved last year, 22, is less than half of the 45 approved in 2015 and lower than the average of the last 10 years of approvals, which is 29. 

January 6, 2017
This is the fifth approved indication for Lucentis. 
January 6, 2017

U.S. District Court Judge Sue Robinson on Thursday issued an injunction on the sale of Praluent, a PCSK9 inhibitor from Sanofi and Regeneron. Amgen, maker of another PCSK9 inhibitor Repatha, filed the request for the injunction in 2016.